Search results

Order by most recent / most popular / relevance

Results: 1-10 of 54

Apotex v. Canada (Minister of Health)

Gowling Lafleur Henderson LLP
-
Canada
-
May 28 2009

Apotex brought a judicial review of the Minister’s refusal to issue a NOC regarding its version of aspirin

AstraZeneca v. Apotex; interlocutory motion for reply evidence; esomeprazole

Gowling Lafleur Henderson LLP
-
Canada
-
February 12 2010

The Court dismissed AstraZeneca's appeal from the order of a prothonotary refusing to strike parts of Apotex' evidence and refusing to permit the applicants to file reply

Bristol-Myers Squibb v. Apotex

Gowling Lafleur Henderson LLP
-
Canada
-
April 7 2009

The Court refused to grant prohibition on the basis that Apotex's allegation in respect of invalidity for obviousness was justified

Apotex v. Adir

Gowling Lafleur Henderson LLP
-
Canada
-
July 27 2009

The Court of Appeal upheld the decision of the Trial Division finding that the patent was both valid and infringed

Sanofi v. Hospira, merits of a 55.2 proceeding

Gowling Lafleur Henderson LLP
-
Canada
-
December 3 2009

The Court refused to grant an Order of Prohibition against Hospira regarding its docetaxel product

Pfizer v. ratiopharm, motion to amended a previous judgment on the merits

Gowling Lafleur Henderson LLP
-
Canada
-
December 3 2009

ratiopharm was successful in the proceeding under the NOC Regulations at the trial level, but the decision was overturned on appeal

Eli Lilly v. Hospira, interlocutory motion regarding further and better affidavit of documents

Gowling Lafleur Henderson LLP
-
Canada
-
January 20 2010

In a case of patent infringement, the Case Management Prothonotary had ordered Hospira to produce a further and better Affidavit of Documents pursuant to an earlier motion by the Plaintiffs

Eli Lilly v. Apotex

Gowling Lafleur Henderson LLP
-
Canada
-
May 4 2009

In the underlying decision on the merits, the Federal Court dismissed the application on the basis that the allegation as to a lack of sound prediction because the patent lacks adequate disclosure was justified

Apotex v. Pfizer

Gowling Lafleur Henderson LLP
-
Canada
-
March 4 2009

The Court of Appeal dismissed the generic company's appeal and upheld the decision of the trial judge prohibiting Apotex entering the market until the expiry of the patent

Abbott v. Sandoz

Gowling Lafleur Henderson LLP
-
Canada
-
April 7 2009

The Court of Appeal dismissed the innovator's appeal regarding a finding that the allegation of invalidity was justified

next >